National Health Insurance: What Behavior Will We Pay For?
When I examine a payment method, I start with the decision it encourages doctors and managers to make. That is how a financial arrangement reaches the patient.
This post is a translation of the original Arabic article.
In Cura's early days, we tried different consultation prices. At one stage, we settled on a flat price of around SAR 40. I wanted users to understand and try the service, with fewer decisions to make when choosing a doctor. It was a decision suited to a particular stage of the company.
Pricing reveals what an organization is trying to achieve. A price that encourages someone to try a new service serves one purpose. Paying doctors in a way that supports their availability and commitment serves another. As the service grows, the calculation changes again.
That was my starting point when explaining national health insurance: how will money be allocated, and what will a provider be paid for?
Pay for each visit, and visit volume enters the financial calculation. Fund an organization to care for a defined population over time, and prevention, follow-up, and the cost of complications become part of that calculation. Each method creates incentives and requires safeguards for patients and care quality.
The World Health Organization describes strategic purchasing through funding decisions informed by population needs and provider performance. This gives the purchaser a demanding job: defining the care required, selecting providers, and designing the payment and its conditions.
Consider two clusters serving the same number of residents. One serves a larger share of older people and patients with complex needs. Equal funding per person would give those clusters different abilities to deliver care. Fair allocation requires an understanding of who is being served and what care they need.
The results also need interpretation. Lower costs may come from better purchasing or follow-up. They may also come from postponed care. Financial performance should be read alongside access times and what happened to patients' health.
The intended institutional roles in Saudi health transformation distinguish funding from care delivery. The funding function succeeds when it rewards the behavior we want: appropriate treatment, timely access, and follow-up that protects the result.
When I examine a payment method, I start with the decision it encourages doctors and managers to make. That is how a financial arrangement reaches the patient.
